The International Trade Commission is publishing notices in the Nov. 7 Federal Register on the following AD/CV injury, Section 337 patent, and other trade proceedings (any notices that warrant a more detailed summary will appear in another ITT article):
The International Trade Administration published notices in the Nov. 7 Federal Register on the following AD/CV proceedings (any notices that announce changes to AD/CV duty rates, scope, affected firms, or effective dates will be detailed in another ITT article):
The International Trade Administration issued the preliminary results of its administrative review of the antidumping duty order on carbon and certain alloy steel wire rod from Mexico (A-201-830) for one company, finding an AD rate of 12.31 percent for Deacero.1 These preliminary results are not in effect. The ITA may modify them in the final results of this review and change the estimated AD cash deposit rate for this company.
The International Trade Administration issued the preliminary results of its administrative review of the antidumping duty order on steel wire garment hangers from China (A-570-918) for one company, the Shanghai Wells Group,1 and the China-wide entity. These preliminary results are not in effect. The ITA may modify them in the final results of this review and change the estimated AD cash deposit rate for this company.
On Nov. 6 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
The Food and Drug Administration threatened Canadian manufacturer International Laboratories (Canada) with refusal of its pharmaceutical products and denial of new applications if the company does not correct violations of the Current Good Manufacturing Practice (CGMP) regulations. The FDA warning letter, dated Oct. 23, also said the firm failed to list net contents in U.S. measurements, and listed ingredients considered by FDA to be inactive as active ingredients. FDA said the company has 15 working days from receipt of the letter to notify it of corrective actions.
The Food and Drug Administration will conduct a reinspection of Indonesian device manufacturer Sugih Instrumendo Abadi’s West Java manufacturing facility after finding violations of Current Good Manufacturing Practice requirements of the quality system regulation, it said in an Oct. 22 warning letter. FDA will also refuse pre-market approval applications for Class III devices from the company related to the violations, it said.
On Nov. 6 the Foreign Agricultural Service issued the following GAIN reports:
The Foreign Trade Zones Board issued the following notices for Nov. 7:
Amazon published a free manual on exporting for retail businesses, entitled “Global Selling with Amazon.” The manual, available only on Amazon’s Kindle e-reader, is a guide “to help sellers expand their business globally by providing an overview of this opportunity, steps that you should take when you expand your business to other marketplaces, and some solutions developed by Amazon to help you sell and fulfill your customer orders,” Amazon said. The manual also includes information on topics including customs; taxation; intellectual property rights; parallel importation; export controls; markings and labels; environmental, health, and safety; and product compliance.